Announcements Trials

Browse Landscape

Status

Not yet recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Biliary Tract Neoplasms 2 Advanced or Metastatic Solid Tumors 2 Thymoma 1 Solid Tumor 1 Sarcoma 1 Piebaldism 1 Gastrointestinal Stromal Tumors 1 Endometrial Neoplasms 1 Colorectal Neoplasms 1 Carcinoma, Renal Cell 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Hepatocellular 1 Advanced Solid Tumor 1

Interventions

tislelizumab 4 pembrolizumab 4 Injections 4 toripalimab 3 sotorasib 1 serabelisib 1 olaparib 1 nedaplatin 1 mirdametinib 1 erdafitinib 1 envafolimab 1 darolutamide 1 atezolizumab 1 adagrasib 1 abiraterone 1 Taxes 1 Nivolumab 1 Magnetic Resonance Spectroscopy 1 Fulvestrant 1 Drug Therapy 1 CD3 Complex 1 Bevacizumab 1 Antineoplastic Agents 1 Albumin-Bound Paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Advanced Solid Tumor × envafolimab × 90 days × Clear all

NCT07562347 2026-05-01

ENCOMPASS STUD

IR INNOVATE RESEARCH PRIVATE LIMITED

Not yet recruiting

Other solid neoplasm

Advanced Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡